# Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

> **NCT00547612** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 33 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **OTHER:** high performance liquid chromatography
- **OTHER:** pharmacological study
- **RADIATION:** [18F]-labeled substance P antagonist receptor quantifier

## Key facts

- **NCT ID:** NCT00547612
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2012-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547612, "Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00547612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*